Expert Profile

Share QR code Edit Profile

Tung Wynn

Clinical Associate Professor

MD-PEDS-HEMATOLOGY | COLLEGE-MEDICINE

View:

Select
All (all in one) Research Terms and Keywords Publications Co-Investigator Network Websites Contact

All
Research
Publications
Network
Websites
Contact

Research Terms & Keywords

Research Terms

Pediatrics

Research Projects

Ends

Title

09-2023

Public Health Surveillance for the Prevention of Complications of Bleeding Disorders Public Health Surveillance for the Prevention of Complications of Bleeding Disorders

08-2023

ATHN Data Quality Counts (DQC) Program - Round 14 ATHN Data Quality Counts (DQC) Program - Round 14

06-2023

DISPLACE: Dissemination and Implementation of Stoke Prevention looking at the Care Environment DISPLACE: Dissemination and Implementation of Stoke Prevention looking at the Care Environment

01-2023

Upper Extremity Exercise to Improve Vascular Volume, Ease of IV Infusions, Factor Compliance, and Quality of Life in Patients with Hemophilia Upper Extremity Exercise to Improve Vascular Volume, Ease of IV Infusions, Factor Compliance, and Quality of Life in Patients with Hemophilia

09-2022

Public Health Surveillance for the Prevention of Complications of Bleeding Disorders Public Health Surveillance for the Prevention of Complications of Bleeding Disorders

08-2022

ATHN Data Quality Counts (DQC) Program - Round 13 ATHN Data Quality Counts (DQC) Program - Round 13

05-2022

Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program. Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program.

09-2021

Public Health Surveillance for the Prevention of Complications of Bleeding Disorders Public Health Surveillance for the Prevention of Complications of Bleeding Disorders

08-2021

ATHN Data Quality Counts (DQC) Award Round 12 ATHN Data Quality Counts (DQC) Award Round 12

05-2021

Hemophilia Treatment Centers (SPRANS) Southeast Region Maternal and Child Health Bureau (MCHB) Bleeding Disorders Program Hemophilia Treatment Centers (SPRANS) Southeast Region Maternal and Child Health Bureau (MCHB) Bleeding Disorders Program

09-2020

Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders

09-2020

Public Health Surveillance for the Prevention of Complications of Bleeding Disorders Project. Public Health Surveillance for the Prevention of Complications of Bleeding Disorders Project.

08-2020

ATHN Data Quality Counts 10 ATHN Data Quality Counts 10

05-2020

Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program. Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program.

02-2020

A Multinational Phase IV Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis A Multinational Phase IV Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis

12-2019

Phase 3b Continuation study of the Safety and Efficacy of PEGylated Recombinant Factor VIII (PEG-rFVIII; BAX 855) in Prophylaxis of Bleeding inPreviously Treated Patients with Severe Hemophilia A Phase 3b Continuation study of the Safety and Efficacy of PEGylated Recombinant Factor VIII (PEG-rFVIII; BAX 855) in Prophylaxis of Bleeding inPreviously Treated Patients with Severe Hemophilia A

05-2019

Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program

09-2018

Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders

05-2018

Southeast Region Maternal and Child Health Bureau Bleeding Disorders Program Southeast Region Maternal and Child Health Bureau Bleeding Disorders Program

12-2017

Multicenter, open-label, randomised, pharmacokinetic (PK) and pharmacodynamic (PD) dose-ranging Phase II study of ticagrelor followed by a double-blind, randomised, parallel-group, placebo-controlled 4 weeks extension phase in paediatric Multicenter, open-label, randomised, pharmacokinetic (PK) and pharmacodynamic (PD) dose-ranging Phase II study of ticagrelor followed by a double-blind, randomised, parallel-group, placebo-controlled 4 weeks extension phase in paediatric

10-2017

30-day, open-label, active-controlled, randomized study of the safety, efficacy and the pharmacokinetic and pharmacodynamic properties of oral rivaroxaban in young children with various manifestations of venous thrombosis 30-day, open-label, active-controlled, randomized study of the safety, efficacy and the pharmacokinetic and pharmacodynamic properties of oral rivaroxaban in young children with various manifestations of venous thrombosis

10-2017

Multicenter, open-label, active-controlled, randomized study to evaluate the efficacy and safety of an age-and body weight-adjusted rivaroxaban regimen compared to standard of care in children with acute venous thromboembolism Multicenter, open-label, active-controlled, randomized study to evaluate the efficacy and safety of an age-and body weight-adjusted rivaroxaban regimen compared to standard of care in children with acute venous thromboembolism

09-2017

Community Counts Public Health Surveillance for Bleeding Disorders Project Community Counts Public Health Surveillance for Bleeding Disorders Project

07-2017

A PHASE 3 PROSPECTIVE, UNCONTROLLED, MULTICENTER STUDY EVALUATING PHARMACOKINETICS, EFFICACY, SAFETY, AND IMMUNOGENICITY OF BAX 855 (PEGYLATEDFULL-LENGTH RECOMBINANT FVIII) IN PREVIOUSLY TREATED PEDIATRIC PATIENTS WITH SEVERE HEMOPHILIA A A PHASE 3 PROSPECTIVE, UNCONTROLLED, MULTICENTER STUDY EVALUATING PHARMACOKINETICS, EFFICACY, SAFETY, AND IMMUNOGENICITY OF BAX 855 (PEGYLATEDFULL-LENGTH RECOMBINANT FVIII) IN PREVIOUSLY TREATED PEDIATRIC PATIENTS WITH SEVERE HEMOPHILIA A

05-2017

Southeast Region Comprehensive and Diagnostic Bleeding Disorders Treatment Center Program Southeast Region Comprehensive and Diagnostic Bleeding Disorders Treatment Center Program

04-2017

Single-dose pilot study of oral rivaroxaban in pediatric subjects with venous thromboembolism. Single-dose pilot study of oral rivaroxaban in pediatric subjects with venous thromboembolism.

01-2017

A Phase 3, Multi-Center, Open Label Study of Efficacy and Safety of PEGylated rFVIII (BAX855) in Previously Treated Patients with Severe Hemophilia A Undergoing Surgical or Other Invasive Procedures A Phase 3, Multi-Center, Open Label Study of Efficacy and Safety of PEGylated rFVIII (BAX855) in Previously Treated Patients with Severe Hemophilia A Undergoing Surgical or Other Invasive Procedures

01-2016

Guardian 4 Guardian 4

06-2015

PEGylated rFVIII (BAX 855) PEGylated rFVIII (BAX 855)

Publications

Search Google Scholar for Tung Wynn

Co-Investigator Network

Lucien Black

Clinical Associate Professor

University of Florida

VM-PHY SCI, Pediatrics

vblack@peds.ufl.edu

Anita Rajasekhar

Professor

University of Florida

MD-HEMATOLOGY/ONCOLOGY, College-Medicine

rajasa@medicine.ufl.edu

Amy Ramirez

University of Florida

MD-PEDS-ADMINISTRATION, College-Medicine

amyramirez@ufl.edu

Websites

0000-0002-7331-4364

Search Google Scholar for Tung Wynn

Contact Information

twynn@ufl.edu

3522739120

PO BOX 100298
GAINESVILLE, Fl 326100001

Profile QR code

What is this?

Tung Wynn

Clinical Associate Professor

MD-PEDS-HEMATOLOGY | COLLEGE-MEDICINE

Research Terms & Keywords

Research Projects

Publications

Co-Investigator Network

Websites

Contact Information

About

Discover

Connect

Keyword Search

Browse by STEM